Siegers C P, Steffen B, Younes M
Institute of Toxicology, Medical University of Lübeck, Federal Republic of Germany.
Pharmacol Res Commun. 1988 Apr;20(4):337-43. doi: 10.1016/s0031-6989(88)80070-5.
Pretreatment with deferrioxamine (DFO, 125-500 mg/kg i.p.) protected male mice against CCl4- or CBrCl3-induced hepatotoxicity which is closely related to an inhibition of iron-dependent lipid peroxidation monitored by ethane exhalation. For allyl alcohol, 1,1-dichloroethylene, dimethylnitrosamine, thioacetamide, bromobenzene and paracetamol no hepatoprotection was achieved with DFO indicating that lipid peroxidation is not involved as a primary mechanism of toxicity. In the case of bromobenzene a marked in vivo lipid peroxidation was observed, which was unaffected by DFO and appears therefore to be iron-dependent.
用去铁胺(DFO,腹腔注射125 - 500 mg/kg)预处理可保护雄性小鼠免受四氯化碳或三溴氯甲烷诱导的肝毒性,这与通过乙烷呼出量监测的铁依赖性脂质过氧化的抑制密切相关。对于烯丙醇、1,1 - 二氯乙烯、二甲基亚硝胺、硫代乙酰胺、溴苯和对乙酰氨基酚,DFO未实现肝保护,表明脂质过氧化不是主要的毒性机制。在溴苯的情况下,观察到明显的体内脂质过氧化,其不受DFO影响,因此似乎是铁依赖性的。